Scientific Program - ESR Annual Meeting 2025

Scientific Program


ESR Vasculitis Day
14:00Registration
14:45 – 15:15Welcome Coffee Reception
15:15 – 17:30Track A
Moderators: Dr. Shamma Al Nokhatha and Dr. Fahad Fazal
15:15 – 15:45Behçet’s Disease: Navigating the Many Faces of a Complex DisorderDr. Ibrahim Almaghlouth
15:45 – 16:15Emerging Insights in Takayasu ArteritisProf. David Saadoun
16:15 – 16:45Giant Cell Arteritis: Evolving Paradigms in Diagnosis and TreatmentProf. Aladdin Mohammad
16:45 – 17:15Vessels in Flame: Targeting Complement for Precision Medicine in ANCA-associated VasculitisProf. Björn Tampe
17:15 – 17:30Q&A
17:30 – 17:45Coffee Break
15:15 – 17:30Track B
Moderator: Dr. Mumtaz Khan
17:45 – 18:15The Invisible Inflammation: Uncovering CNS Vasculitis & CryoglobulinemiaProf. David Saadoun
18:15 – 18:45MRI in CNS Small Vessel Vasculitis and MimicsDr. Iftikhar Ahmad
18:45 – 19:15ANCA Vasculitis in 2025: Evolving Evidence and Emerging TherapiesProf. Aladdin Mohammad
19:15 – 19:45Q&A
19:45 – 20:15Industry Symposium by Vifor
End-of-Day Dinner (Foyer Area)

Main Conference Day 1


07:30 – 15:00 Registration
08:30 – 09:50 Session 1: CAR T & Artificial Intelligence
Moderators: Dr. Najla Aljaberi & Dr. Tahir Khan
08:30 – 08:50 Keynote Lecture: Adopting New Artificial Intelligence (AI) Trends to Reshape Rheumatology Practice Dr. Thomas Hügle
08:50 – 09:20 Making Sense of CAR T in Autoimmune Conditions Dr. Chris Wincup
09:20 – 09:40 CAR T in Lupus – UAE Experience Dr. Tahir Khan
09:40 – 09:50 Q&A & Certificates
09:50 – 10:10 Opening Ceremony
10:10 – 10:40 Industry Symposium by Novartis
10:40 – 10:55 Coffee Break
10:55 – 12:25 Session 2: WIN: What is New?
10:55 – 11:20 Everything you Need to Know About GLP-1 Receptor Agonists and SGLT-2 Inhibitors Dr. Elamin Abdelgadir
11:20 – 11:45 Bridging Gaps in JAKi Use Beyond Arthritis Dr. Daniel Furst
11:45 – 11:55 Q&A & Certificates
11:55 – 12:25 Industry Symposium by Pfizer
12:25 – 13:40 Lunch
13:30 – 16:25 Session 3: Systemic Lupus Erythematosus (SLE) / Antiphospholipid Syndrome (APS)
Moderator: Dr. Samar Al Emadi
13:30 – 13:50 Lupus Nephris Under the Lens: What’s New? What’s Next? Dr. Oseme Etome
13:50 – 14:10 Pitfalls of the 2023 ACR/EULAR Antiphospholipid Syndrome (APS) Classification Criteria Prof. Munther Khamashta
14:10 – 14:50 Decoding Systemic Lupus Erythematosus (SLE) / Antiphospholipid Syndrome (APS) in Pregnancy Dr. Oseme Etome
14:50 – 15:00 Q&A & Certificates
15:00 – 15:30 Industry Symposium by AbbVie
15:30 – 15:45 Coffee Break
15:45 – 16:15 Industry Symposium by Novartis
16:15 – 17:25 Session 4: Rheumatoid Arthritis (RA)
Moderators: Dr. Hanan Al Rayes & Dr. Nizar Abdulateef
16:15 – 16:45 Cracking the Code of Difficult-to-Treat RA Dr. Daniel Furst
16:45 – 17:15 Infection in Rheumatic Conditions: Use of immunomodulators in HIV infection Dr. Aqeel Salem
17:15 – 17:25 Q&A & Certificates
17:25 – 18:30 Session 5: Neoplasia and Rheumatology
Moderator: Dr. Tariq Aslam
17:25 – 17:50 Check it Out! What is New in Check Point Inhibitors in Rheumatology Dr. Chris Wincup
17:50 – 18:20 DMARDs and Malignancy. Cancer Screening, EULAR Guidance and Beyond Dr. Ahmed Zayat
18:20 – 18:30 Q&A & Certificates
END OF DAY
07:30 – 15:00Registration
09:50 – 10:00Welcome RemarksDr. Bashayer Al Nuaimi
10:00 – 11:45Pediatric Session 1
10:00 – 10:35Monogenic Lupus: Insights into Clinical and Genetic ComplexityDr. Sulaiman Almayouf
10:35 – 11:10Approach to variant of unknown significance interpretation in SLEDr. Adnan AlAli
11:10 – 11:45Atypical Presentations of Juvenile SLEDr. Reem Abdawani
11:45 – 12:00Coffee Break
12:00 – 13:45Pediatric Session 2
12:00 – 12:35Vasculitis in Children: Diagnosis, Management, and Long-Term OutcomesDr. Buthaina Al Athba
12:35 – 13:10Optimizing the Transition from Pediatric to Adult Care: An Expert OpinionDr. Elsadeg Sharif
13:10 – 13:45Targeting the JAK–STAT Pathway in Monogenic Interferonopathies: Clinical Advances and ChallengesDr. Shima Kamal
12:35 – 14:45Lunch

END OF DAY

Main Conference Day 2


07:30 – 15:00 Registration
08:30 – 10:25 Session 6: How to Treat? HOT
Moderator: Dr. Humaid Al Wahshi
08:30 – 08:55 Osteoporosis in Males and Young Adults Dr. Asma Aljaberi
08:55 – 09:20 Sequential Therapy in Osteoporosis Dr. Mustafa Al Izzi
09:20 – 09:45 Sjögren’s – Sicca Symptoms to Sjögren’s Dr. Thomas Hügle
09:45 – 09:55 Q&A & Certificates
09:55 – 10:25 Industry Symposium by Lilly
10:25 – 10:45 Coffee Break
10:45 – 11:15 Industry Symposium by Novartis
11:15 – 12:15 Session 7: How to Treat? HOT
Moderators: Dr. Amel Ginawi & Dr. Saadeya Naji
11:15 – 11:40 EULAR /PReS recommendation for the management of Still’s disease Dr. Fatemah Baron
11:40 – 12:05 Connective Tissue Disease-associated Interstitial Lung Disease (CTD-ILD) Dr. Mira Merashli
12:05 – 12:15 Q&A & Certificates
12:15 – 13:20 Lunch
13:20 – 14:35 Session 8: Metabolic Diseases
Moderator: Dr. Ahlam Al Marzooqi
13:20 – 14:00 Asymptomatic Hyperuricemia – To Treat or Not to Treat. A Debate Dr. Francis Kynaston-Pearson Dr. Elhadi Eltayeb Abbas
14:00 – 14:25 DMARDs Induced Hepatic Stress: Navigating fatty liver disease and Hepatitis B,C infection Dr. Saeed AlMarzooqi
14:25 – 14:35 Q&A & Certificates
14:35 – 14:50 Coffee Break
14:50 – 15:50 Session 9: Spondyloarthritis (SpA)
14:50 – 15:15 Through the Eye of Inflammation: Uveitis in Rheumatology Practice Dr. Aniruddha Agarwal
15:15 – 15:40 The Art and Science of Rheumatology: Bridging Evidence and Experience in D2T SpA Dr. Asal Adnan
15:40 – 15:50 Q&A & Certificates
15:40 – 15:50 Closing

*Disclaimer: Preliminary Agenda as of 28 October 2025, subject to potential modifications without prior notification.

REGISTER NOW